contemporarypediatrics3 天
Anna Reed, MD, MPH
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics3 天
Nathan Hitzeman, MD
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics3 天
Maria D McColgan, MD, MSEd, FAAP
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics4 天
FDA approves first generic GLP-1 injection for type 2 diabetes in patients 10 years and up
The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up. The US Food and Drug Administration (FDA) has ...
contemporarypediatrics4 天
FDA approves concizumab-mtci prophylaxis for hemophilia A and B
The indication is for patients 12 years and older hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors. The FDA has approved concizumab-mtci (Alhemo; Novo Nordisk) in ...
contemporarypediatrics4 天
Michael I. Reiff, MD
Keeping up with type 1 diabetes technology changes in primary care ...